Not applicableStudy completedNCT06285110What this trial is testingHIV-1 Subtype-specific Drug Resistance in Patients Failing Dolutegravir (DTG) Based RegimenWho this might be right forHiv University of Bern 1,103
Post-approval studies (Phase 4)Study completedNCT00324688What this trial is testingSafety Study of Once a Day ART and Opiate Substitute.Who this might be right forHIV Infections Gilead Sciences 60
Testing effectiveness (Phase 2)Study completedNCT00000918What this trial is testingCompare The Ability of Different Anti-HIV Drugs to Decrease Viral Load After Nelfinavir (an Anti-HIV Drug)Treatment FailureWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 300
Not applicableStudy completedNCT00005936What this trial is testingCollection of Liver Tissue for Virologic StudiesWho this might be right forVirus Disease National Heart, Lung, and Blood Institute (NHLBI) 50
Not applicableStudy completedNCT01061957What this trial is testingRaltegravir Treatment in Patients Failing Highly Active Antiretroviral Therapy (HAART) in DenmarkWho this might be right forHIV Infections Rigshospitalet, Denmark 96
Not applicableStudy completedNCT01976715What this trial is testingStudy of People With HIV Infection Who Have High Viral Loads Despite Combination Antiretroviral TherapyWho this might be right forAcquired Immune Deficiency Syndrome VirusAcquired Immunodeficiency Syndrome VirusAIDS Virus+2 more National Institute of Allergy and Infectious Diseases (NIAID) 26
Large-scale testing (Phase 3)Active Not RecruitingNCT02951052What this trial is testingStudy Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine From Current Antiretroviral Regimen in Virologically Suppressed HIV-1-infected AdultsWho this might be right forInfection, Human Immunodeficiency VirusHIV Infections ViiV Healthcare 618
Not applicableStudy completedNCT01346878What this trial is testingAntiretroviral Resistance Detection by Ultrasensitive Pyrosequencing of the HIV-1 Genome and Virological Response to Antiretroviral Rescue TreatmentWho this might be right forHIV Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia 143
Not applicableNot Yet RecruitingNCT07620652What this trial is testingPilot Study to Evaluate Efficacy and Safety of Switching to BIC/FTC/TAF in PWH With a Previous Virological Failure Under CAB/RPV LAIWho this might be right forHIV Infection Cristina Mussini 30
Testing effectiveness (Phase 2)Study completedNCT01609933What this trial is testingEvaluate the Safety and Effect of Treatment With Experimental Antiviral Drugs in Combination With Peginterferon Alpha-2a and Ribavirin in People With Hepatitis C Virus Who Did Not Respond to Treatment in a Previous AbbVie/Abbott Combination StudyWho this might be right forChronic Hepatitis C AbbVie (prior sponsor, Abbott) 32
Not applicableStudy completedNCT04612452What this trial is testingThe DTG-SWITCH Study: Longitudinal Analysis of Virologic Failure and Drug Resistance at and After Switching to Dolutegravir-based First-line ARTWho this might be right forHivDrug ResistancyVirologic Failure University of Bern 2,820
Not applicableStudy completedNCT01328275What this trial is testingProgress Adult StudyWho this might be right forHIVDepression The HIV Netherlands Australia Thailand Research Collaboration 5,600
Not applicableStudy completedNCT01044810What this trial is testingEffectiveness of Efavirenz-based Regimen in HIV-1-infected Patients With Nevirapine HypersensitivityWho this might be right forTreatment Failure, HIV or AIDSCD4 Cell Counts Bamrasnaradura Infectious Diseases Institute 559
Early research (Phase 1)Study completedNCT00091741What this trial is testingSafety and Efficacy Study of Etanercept (Enbrel) on the Response Rate of HIV-infected SubjectsWho this might be right forHIV Infection Georgetown University 10
Post-approval studies (Phase 4)Study completedNCT05243602What this trial is testingBFTAF Elderly Switch StudyWho this might be right forHIV-1-infection University of Nairobi 520
Large-scale testing (Phase 3)Study completedNCT00359021What this trial is testingAn Open-label Trial With TMC125 in Patients Who Have Virologically Failed in a DUET Trial (TMC125-C206 or TMC125-C216).Who this might be right forHIV-1 Tibotec Pharmaceuticals, Ireland 503
Testing effectiveness (Phase 2)Study completedNCT00000885What this trial is testingTreatment Success and Failure in HIV-Infected Subjects Receiving Indinavir in Combination With Nucleoside Analogs: A Rollover Study for ACTG 320Who this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 440
Testing effectiveness (Phase 2)Study completedNCT00615134What this trial is testingINNOVE Study: A Study of 3 Months Induction With Fuzeon (Enfuvirtide) + Optimized Background (OB) Versus OB Alone in HIV-1 Infected Patients With Virological Failure.Who this might be right forHIV Infections Hoffmann-La Roche 29
Not applicableStudy completedNCT00608569What this trial is testingDetermining the Effects of Observed and Self-Administered Drug Regimens in HIV Infected AdultsWho this might be right forHIV Infections Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 529
Not applicableStudy completedNCT00188851What this trial is testingStructured Treatment Interruption for HIV Patients With Virologic FailureWho this might be right forHIV University Health Network, Toronto 196